2020 Year in Review: Pharmacologic Treatments for COVID-19

Respir Care. 2021 Jul;66(7):1167-1172. doi: 10.4187/respcare.09153. Epub 2021 Apr 12.

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, has led to a pandemic of acute respiratory illness. Pharmacologic treatments for COVID-19 have included treatments that target infection prevention, prevention of viral replication, reduce inflammation, and manage symptoms of respiratory failure caused by the disease. This is a review of key pharmacologic treatments for COVID-19 based on peer-reviewed articles from 2020.

Keywords: COVID-19; Optate; REGN-CoV-2; SARS-CoV-2; airway pH; dexamethasone; remdesivir.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • Pandemics
  • SARS-CoV-2

Substances

  • Antiviral Agents